156 related articles for article (PubMed ID: 11433401)
1. Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.
Eerola H; Vahteristo P; Sarantaus L; Kyyrönen P; Pyrhönen S; Blomqvist C; Pukkala E; Nevanlinna H; Sankila R
Int J Cancer; 2001 Aug; 93(3):368-72. PubMed ID: 11433401
[TBL] [Abstract][Full Text] [Related]
2. Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).
Eerola H; Pukkala E; Pyrhönen S; Blomqvist C; Sankila R; Nevanlinna H
Cancer Causes Control; 2001 Oct; 12(8):739-46. PubMed ID: 11562114
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in hereditary breast cancer kindreds.
Lin KM; Ternent CA; Adams DR; Thorson AG; Blatchford GJ; Christensen MA; Watson P; Lynch HT
Dis Colon Rectum; 1999 Aug; 42(8):1041-5. PubMed ID: 10458128
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.
Sarantaus L; Auranen A; Nevanlinna H
Int J Oncol; 2001 Apr; 18(4):831-5. PubMed ID: 11251181
[TBL] [Abstract][Full Text] [Related]
5. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations.
Gaffney DK; Brohet RM; Lewis CM; Holden JA; Buys SS; Neuhausen SL; Steele L; Avizonis V; Stewart JR; Cannon-Albright LA
Radiother Oncol; 1998 May; 47(2):129-36. PubMed ID: 9683359
[TBL] [Abstract][Full Text] [Related]
6. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
Marcus JN; Watson P; Page DL; Narod SA; Lenoir GM; Tonin P; Linder-Stephenson L; Salerno G; Conway TA; Lynch HT
Cancer; 1996 Feb; 77(4):697-709. PubMed ID: 8616762
[TBL] [Abstract][Full Text] [Related]
7. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.
Pharoah PD; Easton DF; Stockton DL; Gayther S; Ponder BA
Cancer Res; 1999 Feb; 59(4):868-71. PubMed ID: 10029077
[TBL] [Abstract][Full Text] [Related]
8. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
11. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
[TBL] [Abstract][Full Text] [Related]
13. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
14. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
15. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
16. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
[TBL] [Abstract][Full Text] [Related]
17. Survival in hereditary breast cancer associated with germline mutations of BRCA2.
Verhoog LC; Brekelmans CT; Seynaeve C; Dahmen G; van Geel AN; Bartels CC; Tilanus-Linthorst MM; Wagner A; Devilee P; Halley DJ; van den Ouweland AM; Meijers-Heijboer EJ; Klijn JG
J Clin Oncol; 1999 Nov; 17(11):3396-402. PubMed ID: 10550133
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer susceptibility genes. BRCA1 and BRCA2.
Brody LC; Biesecker BB
Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
[TBL] [Abstract][Full Text] [Related]
19. Reproductive factors in hereditary breast cancer.
Jernström HC; Johannsson OT; Loman N; Borg A; Olsson H
Breast Cancer Res Treat; 1999 Dec; 58(3):295-301. PubMed ID: 10718491
[TBL] [Abstract][Full Text] [Related]
20. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.
Johannsson O; Loman N; Möller T; Kristoffersson U; Borg A; Olsson H
Eur J Cancer; 1999 Aug; 35(8):1248-57. PubMed ID: 10615237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
